TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2954077

Group type: EXPERIMENTAL
Intervention: CAF (cyclophosphamide 600 mg/m2 + 5-fluorouracil 750 mg/m2 + adriamycin 45 mg/m2)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: CNF (cyclophosphamide 600 mg/m2 + 5-fluorouracil 750 mg/m2 + mitoxantrone 13 mg/m2)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: CAF
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: CNF
Number of subjects: 142
Study: 31789623

Group type: EXPERIMENTAL
Intervention: Hospital-acquired pressure injury (HAPI)
Number of subjects: 415
Study: 30109375

Group type: EXPERIMENTAL
Intervention: Placebo manipulation consisting of verbal suggestion and conditioning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group informed about the real nature of the cream
Number of subjects: 0
Study: 28393781

Group type: EXPERIMENTAL
Intervention: Levosimendan at 0.1 μg/kg/min
Number of subjects: 80

Group type: COMPARATOR
Intervention: Dobutamine at 5 μg/kg/min
Number of subjects: 80
Study: 26237195

Group type: EXPERIMENTAL
Intervention: Noncircular chainring (NCC)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Conventional circular chainring (CC)
Number of subjects: 11
Study: 25087294

Group type: EXPERIMENTAL
Intervention: Tadalafil/exercise training group (T/E group, n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tadalafil group (T group, n = 10)
Number of subjects: 20
Study: 21167363

Group type: EXPERIMENTAL
Intervention: Weekly training for 4 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Monthly training for 4 months
Number of subjects: 24
Study: 18633699

Group type: EXPERIMENTAL
Intervention: Facilitated PAD session
Number of subjects: 462

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 462
Study: 17152553

Group type: EXPERIMENTAL
Intervention: Monoscopic photography
Number of subjects: 100

Group type: COMPARATOR
Intervention: Stereoscopic photography
Number of subjects: 100
Study: 12860539

Group type: EXPERIMENTAL
Intervention: semitendinosus tendon autograft
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: semitendinosus and gracilis tendon autograft
Number of subjects: 90
Study: 10889125

Group type: EXPERIMENTAL
Intervention: Aggressive lowering of LDL cholesterol levels to <100 mg/dL
Number of subjects: 1351

Group type: EXPERIMENTAL
Intervention: Low-dose anticoagulation
Number of subjects: 1351

Group type: COMPARATOR
Intervention: Moderate reduction of LDL cholesterol to 132-136 mg/dL
Number of subjects: 1351

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1351
Study: 8957147

Group type: EXPERIMENTAL
Intervention: Lofexidine
Number of subjects: 86

Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 86
Study: 1568366

Group type: EXPERIMENTAL
Intervention: d-fenfluramine (d-F) 15 mg, two capsules daily
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (P) 2 capsules daily
Number of subjects: 36
Study: 2864791

Group type: EXPERIMENTAL
Intervention: Imaginal desensitization (ID)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Covert sensitization (CS)
Number of subjects: 20
Study: 30763041

Group type: EXPERIMENTAL
Intervention: Interactive tool providing cesarean delivery rate data for 10 closest hospitals
Number of subjects: 18293

Group type: COMPARATOR
Intervention: Control group (no interactive tool)
Number of subjects: 18293

Group type: EXPERIMENTAL
Intervention: Intervention group (with interactive tool)
Number of subjects: 18293
Study: 30053891

Group type: EXPERIMENTAL
Intervention: Long-term abdominal drains (LTAD) for 12 weeks
Number of subjects: 48

Group type: COMPARATOR
Intervention: Current standard of care (large volume paracentesis [LVP]) for 12 weeks
Number of subjects: 48
Study: 27397441

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 mcg/kg loading dose over 15 min, followed by 0.5 mcg/kg/h maintenance infusion)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 60
Study: 23481373

Group type: EXPERIMENTAL
Intervention: Therapist Empathy Scale (TES)
Number of subjects: 315
Study: 21861683

Group type: EXPERIMENTAL
Intervention: Long display durations (displays visible until response onset)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short display durations (displays visible for only 200 msec)
Number of subjects: 0
Study: 20483671

Group type: EXPERIMENTAL
Intervention: Acupuncture for dysmenorrhea
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acupuncture for menopause
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acupuncture for PMS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acupuncture for PCOS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acupuncture for other menstrual related symptoms
Number of subjects: 0
Study: 17073850

Group type: EXPERIMENTAL
Intervention: Propofol with a plasmatic target concentration of 4 mg/l (group P; n= 26)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Sevoflurane 4% with tidal volume ventilation (group S; n= 26)
Number of subjects: 52
Study: 16338276

Group type: COMPARATOR
Intervention: Saquinavir (600 mg) with water (control)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Saquinavir (600 mg) with Seville orange juice
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: CYP3A5 expressors (6 subjects)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: CYP3A5 nonexpressors (14 subjects)
Number of subjects: 20
Study: 11889302

Group type: EXPERIMENTAL
Intervention: NIV‐PAV
Number of subjects: 12

Group type: COMPARATOR
Intervention: NIV‐PSV
Number of subjects: 12
Study: 10716008

Group type: EXPERIMENTAL
Intervention: Patient education brochure (ZDV therapy)
Number of subjects: 653
Study: 7720343

Group type: EXPERIMENTAL
Intervention: Random urine sample with threshold albumin-creatinine ratio of > or = 3.0 mg/mmol
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Overnight urine collection with threshold values of 2.5 mg/mmol for men and 4.5 mg/mmol for women
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Spot albumin-creatinine ratio
Number of subjects: 50
Study: 2119417

Group type: EXPERIMENTAL
Intervention: Pravastatin (10 mg b.i.d. for 6 weeks, then 20 mg b.i.d. for 6 weeks)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Cholestyramine (24 g d-1 or highest tolerable dose)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 6783416

Group type: EXPERIMENTAL
Intervention: Training (45 min/day, 3 times/week for 12 weeks at 80% VO2 max)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (n = 13, age 39 +/- 5.0)
Number of subjects: 24
Study: 29373395

Group type: EXPERIMENTAL
Intervention: Real rDTMS treatment
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham rDTMS treatment
Number of subjects: 48
Study: 28318388

Group type: EXPERIMENTAL
Intervention: Nutritional intervention with individualized nutrition plan (1.0‐1.5 g/kg) and dietary advice
Number of subjects: 55

Group type: COMPARATOR
Intervention: Standard nutritional management (control group)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Nutritional intervention
Number of subjects: 55
Study: 25753895

Group type: EXPERIMENTAL
Intervention: SFA (butter)
Number of subjects: 0

Group type: COMPARATOR
Intervention: n-6PUFA (vegetable oil)
Number of subjects: 0
Study: 23817692

Group type: EXPERIMENTAL
Intervention: SOA combined with tegafur-uracil (group B)
Number of subjects: 52

Group type: COMPARATOR
Intervention: SOA alone (group A)
Number of subjects: 52
Study: 21114350

Group type: EXPERIMENTAL
Intervention: Self-esteem manipulation and death cognition manipulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Death cognition manipulation
Number of subjects: 0
Study: 18249333

Group type: EXPERIMENTAL
Intervention: Hotline group (warmed intravenous fluids to 41 degrees C)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (standardized institutional practice without warmed intravenous fluids)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups (Hotline and Control)
Number of subjects: 40
Study: 16340591

Group type: EXPERIMENTAL
Intervention: Ketamine gel (50 mg/mL), applied topically 10 minutes before capsaicin injection
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 9
Study: 11786767

Group type: EXPERIMENTAL
Intervention: Open hemorrhoidectomy (Group A, n = 40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Closed hemorrhoidectomy (Group B, n = 40)
Number of subjects: 80
Study: 9834769

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 344

Group type: COMPARATOR
Intervention: Fluvastatin
Number of subjects: 344

Group type: COMPARATOR
Intervention: Lovastatin
Number of subjects: 344

Group type: COMPARATOR
Intervention: Simvastatin
Number of subjects: 344
Study: 8087913

Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: General anaesthesia (halothane or isoflurane)
Number of subjects: 0
Study: 2681348

Group type: EXPERIMENTAL
Intervention: Human growth hormone (hGH) alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy with hGH and oxandrolone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 0
Study: 15741980

Group type: EXPERIMENTAL
Intervention: Rehabilitation care for SCI patients in 148 units across metropolitan France
Number of subjects: 934
Study: 495549

Group type: EXPERIMENTAL
Intervention: High-fiber diet
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low-fiber diet
Number of subjects: 12
Study: 29704437

Group type: EXPERIMENTAL
Intervention: SQS + OMM
Number of subjects: 116

Group type: COMPARATOR
Intervention: OMM
Number of subjects: 116
Study: 27655325

Group type: EXPERIMENTAL
Intervention: IV infusion of 1 mL/Kg of crystalloid over 5 minutes
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: IV infusion of 4 mL/Kg of crystalloid over 5 minutes
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 4 mL/Kg of crystalloid
Number of subjects: 80
Study: 26588599

Group type: EXPERIMENTAL
Intervention: Flapless surgical protocol (n = 20 patients; 32 implants)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Flapped surgical protocol (n = 21 patients; 40 implants)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Overall (both groups)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Flap group
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Flapless group
Number of subjects: 41
Study: 24982464

Group type: EXPERIMENTAL
Intervention: VAC (vincristine, dactinomycin, and cyclophosphamide) with 1.5 g/m² of cyclophosphamide
Number of subjects: 856

Group type: COMPARATOR
Intervention: VAI (vincristine, dactinomycin, and ifosfamide) with 6 g/m² of ifosfamide
Number of subjects: 856

Group type: EXPERIMENTAL
Intervention: VAC
Number of subjects: 856

Group type: COMPARATOR
Intervention: VAI
Number of subjects: 856
Study: 21945511

Group type: EXPERIMENTAL
Intervention: MK-0633 100 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MK-0633 (various doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MK-0633
Number of subjects: 0
Study: 19244263

Group type: EXPERIMENTAL
Intervention: Levobupivacaine infusion for femoral nerve
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Levobupivacaine infusion for sciatic nerve
Number of subjects: 24

Group type: COMPARATOR
Intervention: Comparison of EC50 for femoral vs sciatic nerve
Number of subjects: 24
Study: 17120172

Group type: EXPERIMENTAL
Intervention: Local anesthesia with IV sedation
Number of subjects: 40

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 40
Study: 15102865

Group type: EXPERIMENTAL
Intervention: Automated blood pressure measurement
Number of subjects: 20

Group type: COMPARATOR
Intervention: Manual blood pressure measurement
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Triplicate blood pressure measurements
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Phenylephrine infusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Normal saline infusion
Number of subjects: 20
Study: 11984298

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (1200 IU.d‐1 for 30 days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (safflower oil)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both groups (Vitamin E and Placebo)
Number of subjects: 16
Study: 9788829

Group type: EXPERIMENTAL
Intervention: Echocardiography-guided ethanol septal reduction (2 to 5 mL of absolute ethanol injected into the septal artery)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Echocardiography-guided ethanol septal reduction
Number of subjects: 33
Study: 8610215

Group type: EXPERIMENTAL
Intervention: Intramuscular gold
Number of subjects: 128

Group type: COMPARATOR
Intervention: Sulphasalazine
Number of subjects: 128
Study: 2491521

Group type: EXPERIMENTAL
Intervention: 1 g of oral calcium for 8 weeks
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 892953

Group type: EXPERIMENTAL
Intervention: Mandrax + alcohol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nitrazepam + alcohol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mandrax + alcohol placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drug placebo + alcohol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drug + alcohol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drug + alcohol placebo
Number of subjects: 0
Study: 31424421

Group type: EXPERIMENTAL
Intervention: iTBS plus MT
Number of subjects: 18

Group type: COMPARATOR
Intervention: iTBS plus sham MT
Number of subjects: 18

Group type: COMPARATOR
Intervention: sham iTBS plus MT
Number of subjects: 18
Study: 28867442

Group type: EXPERIMENTAL
Intervention: Information about abortion safety
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Comparison group (no information)
Number of subjects: 1200
Study: 24849943

Group type: EXPERIMENTAL
Intervention: Routine epidural analgesia (EA)
Number of subjects: 488

Group type: COMPARATOR
Intervention: Analgesia on request
Number of subjects: 488
Study: 24021094

Group type: EXPERIMENTAL
Intervention: Progressive Goal Attainment Program (PGAP) - 10 weekly individual sessions of structured active rehabilitation in addition to usual care.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual medical care only (Control).
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: PGAP intervention.
Number of subjects: 100
Study: 22409094

Group type: EXPERIMENTAL
Intervention: PNI-based lifestyle intervention (progressive muscle relaxation, spiritual guided imagery, humor)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: PNI-based lifestyle intervention
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (receiving cognitive behavioral therapy and pharmacotherapy)
Number of subjects: 41
Study: 19603054

Group type: EXPERIMENTAL
Intervention: 5‐methyltetrahydrofolate (5‐MTHF) 15 mg/day for 3 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 17338790

Group type: EXPERIMENTAL
Intervention: Laser acupuncture for 10 weeks and probiotic treatment (living non‐pathogenic Enterococcus faecalis) for 7 weeks
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group treated with a laser pen that did not emit laser light and placebo drops
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Laser acupuncture and probiotics
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 17
Study: 15132303

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise training (3 sessions/week for 10 weeks)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Non-exercising control group
Number of subjects: 102
Study: 11234548

Group type: EXPERIMENTAL
Intervention: German factor model of the Conners Parent Rating Scale (CPRS)
Number of subjects: 1394

Group type: COMPARATOR
Intervention: U.S. factor model of the Conners Parent Rating Scale (CPRS)
Number of subjects: 1394
Study: 9740919

Group type: EXPERIMENTAL
Intervention: Comprehensive management approach including preoperative evaluation, meticulous exenterative surgery, supervised immunotherapy, medical management with corticosteroids, patient self-cleansing, and close clinical follow-up.
Number of subjects: 0
Study: 8031347

Group type: EXPERIMENTAL
Intervention: Porcine surfactant (4 g in 50 ml) delivered via bronchoscope
Number of subjects: 6
Study: 10318325

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 29746813

Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate injectable (DMPA)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Levonorgestrel (LNG) implant
Number of subjects: 68

Group type: COMPARATOR
Intervention: TearFlo Strips (TFS)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Cervicovaginal lavage (CVL)
Number of subjects: 68
Study: 27127315

Group type: EXPERIMENTAL
Intervention: Alfuzosin SR 10 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Silodosin 8 mg
Number of subjects: 90
Study: 25589782

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure management (target systolic BP <140 mm Hg)
Number of subjects: 2708

Group type: COMPARATOR
Intervention: Guideline-based blood pressure management (<180 mm Hg)
Number of subjects: 2708
Study: 23203138

Group type: EXPERIMENTAL
Intervention: Trospium chloride XR 60 mg once daily for 10 days in healthy volunteers
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Trospium chloride 60 mg XR once daily for either 2 weeks or 12 weeks in patients with overactive bladder
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Trospium chloride XR 60 mg
Number of subjects: 349
Study: 19828479

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 22
Study: 17710365

Group type: EXPERIMENTAL
Intervention: GLU (1.8 g x kg BW(‐1))
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: GLU + FG (1.8 g x kg BW(‐1) + 1.99 +/‐ 0.20 mg x kg(‐1) 4‐hydroxyisoleucine)
Number of subjects: 20

Group type: COMPARATOR
Intervention: GLU
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: GLU + FG
Number of subjects: 20
Study: 16150265

Group type: EXPERIMENTAL
Intervention: Early discharge (24 hours postpartum)
Number of subjects: 430

Group type: COMPARATOR
Intervention: Control (traditional discharge, more than 48 hours)
Number of subjects: 430
Study: 12502663

Group type: EXPERIMENTAL
Intervention: Insulin lispro
Number of subjects: 1221
Study: 10539835

Group type: EXPERIMENTAL
Intervention: Dofetilide
Number of subjects: 2023

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2023
Study: 7552517

Group type: EXPERIMENTAL
Intervention: Three 100 microgram doses of the inactivated HIV‐1 antigen in incomplete Freund's adjuvant (IFA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Three doses of IFA alone
Number of subjects: 0
Study: 1745512

Group type: EXPERIMENTAL
Intervention: Pilocarpine (2% liquid ophthalmic drop preparation, four drops three times per day for 6 weeks)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (identically appearing solution, same dosing schedule and duration)
Number of subjects: 18
Study: 6751182

Group type: EXPERIMENTAL
Intervention: Combined therapy (nafcillin for 6 weeks plus gentamicin for 2 weeks) in parenteral drug addicts
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Combined therapy (nafcillin for 6 weeks plus gentamicin for 2 weeks) in nonaddicts
Number of subjects: 78

Group type: COMPARATOR
Intervention: Single therapy (nafcillin for 6 weeks) in both groups
Number of subjects: 78
Study: 30779531

Group type: EXPERIMENTAL
Intervention: Avelumab plus Axitinib
Number of subjects: 886

Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 886
Study: 28579056

Group type: EXPERIMENTAL
Intervention: Computer-based oculomotor training
Number of subjects: 11
Study: 27488246

Group type: EXPERIMENTAL
Intervention: Dulaglutide 0.75 mg
Number of subjects: 361

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Dulaglutide
Number of subjects: 361
Study: 25220861

Group type: EXPERIMENTAL
Intervention: Fluoxetine (10-40 mg/day)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Desipramine (50-200 mg/day)
Number of subjects: 232
Study: 23545428

Group type: EXPERIMENTAL
Intervention: Flexible dose morphine/oxycodone (3 mg/2 mg to 24 mg/16 mg)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Oxycodone/acetaminophen (5 mg/325 mg)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Fixed low-dose morphine/oxycodone (3 mg/2 mg)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Equianalgesic morphine/oxycodone
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Flexible dose morphine/oxycodone
Number of subjects: 44
Study: 20593354

Group type: EXPERIMENTAL
Intervention: Water load of 25 ml/kg(BW) in 24 hours
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Water load of 25 ml/kg(BW) in 30 minutes
Number of subjects: 20
Study: 18372584

Group type: EXPERIMENTAL
Intervention: Endurance type exercise training of moderate intensity most days of the week
Number of subjects: 0
Study: 16650156

Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment
Number of subjects: 7
Study: 12824978

Group type: EXPERIMENTAL
Intervention: Intravenous ritodrine (111 microg/min for 20 minutes)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Sublingual nitroglycerin (0.4 mg)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Intravenous sodium chloride 0.9% (placebo)
Number of subjects: 74
Study: 10638892

Group type: EXPERIMENTAL
Intervention: Bupivacaine 4 mg plus fentanyl 20 microg (Group A)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bupivacaine 10 mg (Group B)
Number of subjects: 20
Study: 8683193

Group type: EXPERIMENTAL
Intervention: Inclusion and exclusion tests with varying proportions of old targets to old nontargets and attention conditions (full or divided attention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulation of similarity of old targets and old nontargets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Source confusions in inclusion and exclusion tests
Number of subjects: 0
Study: 8293735

Group type: EXPERIMENTAL
Intervention: Desirable cholesterol test results
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Borderline-high cholesterol test results
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Never tested group in community screening
Number of subjects: 0
Study: 3090492

Group type: EXPERIMENTAL
Intervention: Levonorgestrel‐releasing Norplant implants
Number of subjects: 389

Group type: COMPARATOR
Intervention: Copper intrauterine device
Number of subjects: 389
Study: 30373734

Group type: EXPERIMENTAL
Intervention: Peer support for 1 year
Number of subjects: 355

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 355